Browsing Category
Healthcare Industry News
2469 posts
One shot, three months: Zoetis’ Lenivia earns EU nod for chronic dog pain relief
Zoetis receives EU approval for Lenivia, its first long-acting osteoarthritis antibody for dogs. Learn how this strengthens its leadership in veterinary biologics.
Can Ping An Biomedical regain compliance before May 2026? What investors should know
Ping An Biomedical faces Nasdaq delisting risk after falling below $1 per share. Find out what this means for investors and what could happen next.
Crux raises $6.5m to help employers offer weight-loss and wellness drugs without insurance hurdles
Crux raises 6.5 million dollars to help employers offer affordable GLP-1 and lifestyle drug access. Learn how the platform plans to change benefits delivery.
Will a2z Radiology AI’s unified model become the new gold standard for emergency imaging?
a2z Radiology AI’s unified triage system for abdominal CT gets FDA approval. Find out what this could mean for radiologists and hospital workflows in 2025.
What role do fatty acids play in child brain health and academic success?
Can omega-3s improve literacy in children? New study reveals how EPA and DHA affect brain processes key to reading and writing. Learn what SFI Health found.
Can SIDDHI 2.0 transform Ayurveda into a global pharma powerhouse? CCRAS launches translational R&D push
CCRAS’s SIDDHI 2.0 launch in Vijayawada aims to scale Ayurveda pharma through research-led product development. Explore what it means for global growth.
Adherium (ASX: ADR) turns pilot into performance with RPM success across Allergy Partners
Adherium’s RPM expansion through Allergy Partners hits a key milestone in the U.S., but will 4,000 patients be enough to lift its ASX share price from record lows?
Baroness Blackwood to lead Health Data Research Service as UK fast-tracks NHS data access for medical innovation
Baroness Nicola Blackwood will lead the UK’s new Health Data Research Service, fast-tracking NHS data access for lifesaving research. Read the full update.
How Organigram Global hopes new CEO James Yamanaka will accelerate brand and export strategy
Organigram Global names ex-BAT strategist James Yamanaka CEO, marking a strategic shift toward global growth. Find out what it means for investors today.
Can Kimberly-Clark’s $48.7bn Kenvue deal redefine the future of consumer health and personal care?
Kimberly-Clark's $48.7 billion acquisition of Kenvue is reshaping the consumer health landscape. Find out what it means for the future of CPG and wellness.